Document Detail


Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.
MedLine Citation:
PMID:  12126819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Antiplatelet treatment with aspirin and oral anticoagulants reduces recurrence of ischaemic events after myocardial infarction. We aimed to investigate which of these drugs is more effective in the long term after acute coronary events, and whether the combination of aspirin and oral anticoagulants offers greater benefit than either of these agents alone, without excessive risk of bleeding. METHODS: In a randomised open-label trial in 53 sites, we randomly assigned 999 patients to low-dose aspirin, high-intensity oral anticoagulation, or combined low-dose aspirin and moderate intensity oral anticoagulation. Patients were followed up for a maximum of 26 months. The primary composite endpoint was first occurrence of myocardial infarction, stroke, or death. FINDINGS: The primary endpoint was reached in 31 (9%) of 336 patients on aspirin, in 17 (5%) of 325 on anticoagulants (hazard ratio 0.55 [95% CI 0.30-1.00], p=0.0479), and in 16 (5%) of 332 on combination therapy (0.50 [0.27-0.92], p=0.03). Major bleeding was recorded in three (1%) patients on aspirin, three (1%) on anticoagulants (1.03 [0.21-5.08], p=1.0), and seven (2%) on combination therapy (2.35 [0.61-9.10], p=0.2). Frequency of minor bleeding was 5%, 8% (1.68 [0.92-3.07], p=0.20), and 15% (3.13 [1.82-5.37], p=<0.0001), in the three groups, respectively. 164 patients permanently discontinued the study drug. Analyses were done by intention to treat. INTERPRETATION: In patients recently admitted with acute coronary events, treatment with high-intensity oral anticoagulants or aspirin with medium-intensity oral anticoagulants was more effective than aspirin on its own in reduction of subsequent cardiovascular events and death.
Authors:
Robert F van Es; Jan J C Jonker; Freek W A Verheugt; Jaap W Deckers; Diederick E Grobbee;
Related Documents :
2665469 - Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventr...
19159859 - Superselective embolization of renal hemorrhage occurring after percutaneous coronary i...
10514209 - Systematic review of randomized controlled trials of aspirin and oral anticoagulants in...
3129899 - Fetal heart block, anti-ssa and anti-ssb antibodies. association with intra-uterine gro...
16195779 - Repeated remissions of cushing's disease due to recurrent infarctions of an acth-produc...
21431879 - Mortality due to myocardial infarction in the bavarian population during world cup socc...
22626849 - Assessment of fetal myocardial deformation using speckle tracking techniques.
20621369 - Diastolic ventricular interaction in patients after atrial switch for transposition of ...
3266409 - Ventricular and supraventricular arrhythmias in clinically silent right ventricular inf...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lancet     Volume:  360     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-19     Completed Date:  2002-07-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  109-13     Citation Subset:  AIM; IM    
Affiliation:
Julius Centre for General Practice and Patient Oriented Research, University Medical Centre Utrecht, Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / adverse effects,  therapeutic use*
Aspirin / adverse effects,  therapeutic use*
Female
Hemorrhage / chemically induced
Humans
Male
Myocardial Infarction / etiology,  prevention & control*
Netherlands
Risk Factors
Stroke / etiology,  prevention & control*
Warfarin / adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Anticoagulants; 50-78-2/Aspirin; 81-81-2/Warfarin
Comments/Corrections
Comment In:
Lancet. 2002 Dec 21-28;360(9350):2078; author reply 2078   [PMID:  12504434 ]
ACP J Club. 2003 Jan-Feb;138(1):9   [PMID:  12511121 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term results with immediate androgen suppression and external irradiation in patients with loca...
Next Document:  Assessment of guidelines for good practice in psychosocial care of mothers after stillbirth: a cohor...